熔点 | 255.97 °C |
溶解性 | Soluble in DMSO (≥20 mg/ml), water (<1 mg/ml) at 25 °C, ethanol (69 mg/ml) at 25 °C, and 1eq. HCl (100 mM). |
存贮条件 | 储存温度 2-8°C |
应用 | A potent ATP-competitive inhibitor against receptor TbR-I/ALK5. |
产品介绍 | SB525334是一种有效的,选择性的TGFβ receptor I (ALK5)抑制剂,IC50为14.3 nM,作用于ALK4比作用于ALK5效果低4倍,可抑制ALK2, 3,和6活性。 |
备注 | SB525334 is a potent and selective inhibitor of TGFβ receptor I (ALK5) with IC50 of 14.3 nM, is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2, 3, and 6. |
生化机理 | TGF-β RI Kinase Inhibitor VIII is a cell-permeable quinoxaline compound that acts as a potent, highly selective, ATP-competitive inhibitor against type I TGF-β receptor TβR-I/ALK5 (IC50 = 14.3 nM), while exhibiting 4-fold less potency toward ALK4 (IC50 = 58.5 nM) and little or no activity against ALK2/3/6 and a panel of 26 other commonly studied kinases (≤29% inhibition at 10 μM). TGF-β RI Kinase Inhibitor VIII effectively blocks (by >95%) TGF-β1-induced Smad2/3 activation (2 μM in ELT-3 cultures) and nuclear localization (1 μM in RPTE cultures), as well as TGF-β1-dependent p3TP- and ARE-luciferase transcription (0.1 μM in HaCat cultures). TGF-β RI Kinase Inhibitor VIII is an inhibitor of ACTR-IB, COL1A1(procollagen α1(I)) and PAI-1(plasminogen activator inhibitor-1). |
别名 | SB 525334;SB-525334; 6-[2-(1,1-二甲基乙基)-5-(6-甲基-2-吡啶基)-1H-咪唑-4-基]喹喔啉;6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline;TGF-β RI Kinase Inhibitor VIII;SB-525334 |
SB525334,TGFBR1抑制剂
SB525334 (订货以英文为准)
编号:S129327
CAS号:356559-20-1
分子式:C21H21N5
分子量:343.42
产品名称 | SB525334 |
中文名称 | SB525334,TGFBR1抑制剂 |
CAS号 | 356559-20-1 |
分子式(M.F.) | C21H21N5 |
分子量(M.W.) | 343.42 |
储存条件 | 2-8°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品